The day in conversation for 2026-10-26

The discussion: Marcus: that finding about shorter tau fibrils needing denser active sites changes how we view fibril propagation dynamics; it suggests mass accumulation alone isn't the sole driver of catalytic efficiency. Ines: I agree, but when we look at the coupled model, does that density threshold change if the clearance rate of the beta-peptide is significantly higher than its nucleation rate? That distinction seems crucial for predicting *in vivo* outcomes compared to just studying static fibril structures. Yuki: From my side in genomics, I'm less concerned with the catalytic mechanism and more with how much noise we introduce when we try to measure those site exposures; are we confident that the site exposure tracking in that model isn't overly sensitive to stochastic fluctuations in tau aggregation kinetics? Marcus: We have to rely on